Mackenzie Financial
PTCT icon

Mackenzie Financial’s PTC Therapeutics PTCT Stock Holding History

Mackenzie Financial’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.57M Sell
31,477
-314,206
-91% -$22.7M ﹤0.01% 991
2026
Q1 		$23.6M Buy
345,683
+108,774
+46% +$7.7M 0.03% 381
2025
Q4 		$18M Buy
236,909
+35,117
+17% +$2.55M 0.02% 402
2025
Q3 		$12.4M Buy
201,792
+175,506
+668% +$9.14M 0.02% 462
2025
Q2 		$1.28M Buy
26,286
+194
+0.7% +$9.21K ﹤0.01% 951
2025
Q1 		$1.33M Buy
26,092
+3,316
+15% +$165K ﹤0.01% 897
2024
Q4 		$1.03M Buy
22,776
+12,967
+132% +$555K ﹤0.01% 928
2024
Q3 		$364K Buy
9,809
+440
+5% +$14.7K ﹤0.01% 1107
2024
Q2 		$287K Buy
+9,369
New +$304K ﹤0.01% 1182
2023
Q3 		– Sell
-5,627
Closed -$233K – 1567
2023
Q2 		$233K Sell
5,627
-8,102
-59% -$396K ﹤0.01% 1279
2023
Q1 		$665K Buy
13,729
+7,800
+132% +$357K ﹤0.01% 943
2022
Q4 		$226K Buy
5,929
+1,168
+25% +$48.6K ﹤0.01% 1197
2022
Q3 		$239K Buy
+4,761
New +$233K ﹤0.01% 1178
2019
Q1 		– Sell
-7,060
Closed -$242K – 1297
2018
Q4 		$242K Buy
+7,060
New +$254K ﹤0.01% 1069
2016
Q4 		– Sell
-27,400
Closed -$384K – 714
2016
Q3 		$384K Sell
27,400
-110,800
-80% -$901K ﹤0.01% 531
2016
Q2 		$970K Hold
138,200
– – 0.01% 607
2016
Q1 		$890K Buy
138,200
+36,900
+36% +$640K 0.01% 535
2015
Q4 		$3.28M Buy
101,300
+5,000
+5% +$147K 0.02% 346
2015
Q3 		$2.57M Buy
96,300
+8,900
+10% +$381K 0.02% 379
2015
Q2 		$4.21M Buy
87,400
+32,100
+58% +$1.87M 0.02% 327
2015
Q1 		$3.37M Buy
55,300
+23,800
+76% +$1.45M 0.02% 355
2014
Q4 		$1.63M Buy
+31,500
New +$1.39M 0.01% 457

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Mackenzie Financial's PTCT Position: Q2 2026 in Review

Mackenzie Financial reduced its PTC Therapeutics (PTCT) stake by 91% in Q2 2026, selling an estimated $22.7M and leaving 31,477 shares worth $2.57M. The position accounts for ﹤0.01% of the portfolio, ranked #991.

Mackenzie Financial first reported a position in PTCT in Q4 2014 and has held it in 22 quarters since. The position peaked at $23.6M in Q1 2026. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Mackenzie Financial held 31,477 shares of PTC Therapeutics worth $2.57M as of Q2 2026.
  • Mackenzie Financial sold 314,206 PTC Therapeutics shares in Q2 2026, an estimated $22.7M.
  • PTC Therapeutics made up ﹤0.01% of Mackenzie Financial's portfolio in Q2 2026, its #991 holding.
  • Mackenzie Financial first reported a position in PTC Therapeutics in Q4 2014 and has held it in 22 quarters since.
  • Mackenzie Financial's PTC Therapeutics position peaked at $23.6M in Q1 2026.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.